“…The median tumour size was larger, and lymph node metastases were more common in children compared with adults with PTC microcarcinomas. The frequency of microcarcinomas increased with increasing age of children and adolescent subgroup . In a recent study from St. Louis, USA, Markovina et al .…”
Section: Discussionmentioning
confidence: 91%
“…Previous studies suggested that it is more aggressive at presentation than adult DTC with more likelihood of lymph node and distant metastases and a higher chance of persistent/recurrent disease. Conversely and fortunately, mortality from DTC in children is exceedingly rare and its long‐term outcome is favourable . Due to its rarity and the seemingly different disease profile, its management remains largely empirical and is mostly extrapolated from the management of DTC in adults .…”
Section: Discussionmentioning
confidence: 99%
“…Most of the previous studies were descriptive case series of paediatric DTC . The few studies that compared DTC in children with adults included adults at different ages ranging from 20 to 90 years .…”
Section: Discussionmentioning
confidence: 99%
“…In a recent study from Greece, 34 cases of PTC microcarcinomas identified in a cohort of 93 children and adolescents <21 years were studied . The subgroup with PTC microcarcinomas was also compared with another subgroup of 584 adults with PTC microcarcinomas.…”
Section: Discussionmentioning
confidence: 99%
“…However, it is not clear if this favourable outcome in patients <45 years is consistent across all age groups. In several case series, DTC in paediatric and adolescents (<20 years, referred to thereafter as paediatric DTC) seems to have a different clinicopathological profile and outcome . However, none of the previous studies compared DTC in patients >20 to <45 years with DTC in the paediatric age group (≤20 years).…”
Paediatric DTC is distinct from DTC in the young adults (age >20 to <45 years). It is characterized by a higher rate of extrathyroidal extension, lymph node and distant metastases and a higher risk of persistent/recurrent DTC.
“…The median tumour size was larger, and lymph node metastases were more common in children compared with adults with PTC microcarcinomas. The frequency of microcarcinomas increased with increasing age of children and adolescent subgroup . In a recent study from St. Louis, USA, Markovina et al .…”
Section: Discussionmentioning
confidence: 91%
“…Previous studies suggested that it is more aggressive at presentation than adult DTC with more likelihood of lymph node and distant metastases and a higher chance of persistent/recurrent disease. Conversely and fortunately, mortality from DTC in children is exceedingly rare and its long‐term outcome is favourable . Due to its rarity and the seemingly different disease profile, its management remains largely empirical and is mostly extrapolated from the management of DTC in adults .…”
Section: Discussionmentioning
confidence: 99%
“…Most of the previous studies were descriptive case series of paediatric DTC . The few studies that compared DTC in children with adults included adults at different ages ranging from 20 to 90 years .…”
Section: Discussionmentioning
confidence: 99%
“…In a recent study from Greece, 34 cases of PTC microcarcinomas identified in a cohort of 93 children and adolescents <21 years were studied . The subgroup with PTC microcarcinomas was also compared with another subgroup of 584 adults with PTC microcarcinomas.…”
Section: Discussionmentioning
confidence: 99%
“…However, it is not clear if this favourable outcome in patients <45 years is consistent across all age groups. In several case series, DTC in paediatric and adolescents (<20 years, referred to thereafter as paediatric DTC) seems to have a different clinicopathological profile and outcome . However, none of the previous studies compared DTC in patients >20 to <45 years with DTC in the paediatric age group (≤20 years).…”
Paediatric DTC is distinct from DTC in the young adults (age >20 to <45 years). It is characterized by a higher rate of extrathyroidal extension, lymph node and distant metastases and a higher risk of persistent/recurrent DTC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.